FDA fees rise in latest budget (The Star-Ledger)
WASHINGTON -- The Bush administration yesterday proposed about a $100 million increase in the Food and Drug Administration's budget for fiscal 2008 that includes the first user fee for the generic drug industry as well a big boost in fees paid by brand-name pharmaceutical companies.

FDA Approves New Dosing Recommendations For RAPAMUNE In High Immunologic Risk Renal Transplant Patients (Medical News Today)
Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE), today announced that the U.S. Food and Drug Administration (FDA) has approved new dosing recommendations for its immunosuppressant drug RAPAMUNE(R) (sirolimus). [click link for full article]

ThermoGenesis Corp. Submits Response to FDA on CryoSeal(R) U.S. Pre-Market Approval Application (RedNova)
RANCHO CORDOVA, Calif., Feb. 6 /PRNewswire-FirstCall/ -- ThermoGenesis Corp. announced today that the Company has responded to the U.S.